导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -11.08% | 844/1050 |
| 近一周 | -2.35% | 554/1104 |
| 近一月 | -5.94% | 715/1102 |
| 近一季 | -6.72% | 506/1092 |
| 近半年 | -14.13% | 870/1070 |
| 近一年 | -6.52% | 680/1018 |
| 近两年 | 21.59% | 761/926 |
| 近三年 | 19.68% | 496/834 |
| 成立以来 | 77.92% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.16% 725/1070 |
0.20% 694/1101 |
- - |
- - |
| 2025 | 22.09% 628/1065 |
1.61% 673/1014 |
-0.50% 728/1038 |
19.34% 628/1050 |
1.18% 374/1065 |
| 2024 | 16.37% 144/1011 |
4.29% 123/960 |
4.73% 104/983 |
8.97% 714/991 |
-2.23% 472/1011 |
| 2023 | -0.95% 116/952 |
3.38% 415/880 |
4.13% 52/895 |
-2.37% 172/915 |
-5.75% 584/952 |
| 2022 | -14.45% 159/867 |
-16.93% 355/773 |
10.16% 261/806 |
-7.60% 123/845 |
1.17% 372/867 |
| 2021 | 16.71% 176/740 |
2.00% 89/580 |
-2.19% 566/659 |
4.19% 140/704 |
12.28% 39/740 |
| 2020 | - - |
- - |
- - |
8.98% 276/517 |
11.50% 310/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 大成睿裕六月持有股票A VS. 东吴新产业精选股票A(580008) |